Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Windlas Biotech Merger & Restructuring Worth ₹47 Cr

Windlas Biotech Limited announced a share buyback of 4,70,000 equity shares at ₹1,000 per share via a tender offer, totaling ₹47.00 Crore. The buyback window opens on April 30, 2026, and closes on May 7, 2026. This corporate action aims to return capital to shareholders at a significant premium.

Key figures
Value₹47.00 Cr
Source

NSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Windlas Biotech Ltd: key numbers

Share price
₹876.10
Market cap
₹1,839 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
27.7×Sector 45.9×
Promoter holding
63.31%+0.00% QoQ
FII holding
2.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Windlas Biotech Ltd

All →

Other merger & restructuring announcements

All →